Management of Surgery to Cranioplasty Reconstruction in Meningioma Patients with Hyperostosis: Case Series
(1) Department of Neurosurgery, Faculty of Medicine, Universitas Muhammadiyah Surabaya, Surabaya, East Java, Indonesia
(2) Student of Faculty of Medicine, Universitas Muhammadiyah Surabaya, Surabaya, East Java, Indonesia
(3) Department of Neurology, Faculty of Medicine, Universitas Muhammadiyah Surabaya, Surabaya, East Java, Indonesia
(4) Student of Faculty of Medicine, Universitas Muhammadiyah Surabaya, Surabaya, East Java, Indonesia
(5) Department of Neurology, RSUD dr Soegiri, Lamongan, East Java, Indonesia
(6) Department of Neurology, RSUD dr Soegiri, Lamongan, East Java, Indonesia
(*) Corresponding Author
Abstract
Background: Meningiomas, common primary brain neoplasms, become more frequent with age. They can affect osseous structures, manifesting as hyperostosis and significantly diminishing the well-being of patients. Although meningiomas' precise etiology and pathogenesis remain ambiguous, hormonal influences and other factors have been implicated in their development. This study seeks to explain surgical management and cranioplasty reconstruction to reduce recurrence and improve the well-being of patients.
Objective: This case series encompasses a retrospective analysis of medical records from six patients diagnosed with meningiomas with hyperostosis, treated between December 2022 and January 2024, at Dr. Soegiri General Hospital, Lamongan. The analysis focuses on surgical interventions and cranioplasty reconstruction.
Cases Presentation: Six patients had chronic cephalgia and cranial masses persisting for 3-6 years. Computed tomography imaging revealed hyperostotic changes contiguous with the neoplastic lesions, prompting craniotomy. Subsequent acrylic cranioplasty was undertaken to ensure encephalic protection and to achieve cosmetic restoration.
Conclusion: For patients presenting with meningiomas and hyperostosis, symptomatic management through surgical excision and resection of the hyperostotic bone is recommended. Early implementation of cranioplasty, preferably acrylic materials, is recommended to shield cerebral structures and restore cranial morphology, given its economic feasibility and reduced infection risk compared to autologous bone grafts
Keywords
Full Text:
PDFReferences
Brown NJ, Pennington Z, Kuo CC, Gendreau J, Chakravarti S, Singh R, et al. Meningioma: A Biography—Tumor Forever Tied to the Origins and “Soul of Neurosurgery.” World Neurosurg. 2023 Oct;178:191-201.e1.
Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, et al. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012. Neuro Oncol. 2015 Oct;17(suppl 4):iv1–62.
Buerki RA, Horbinski CM, Kruser T, Horowitz PM, James CD, Lukas R V. An overview of meningiomas. Future Oncology. 2018 Sep;14(21):2161–77.
Alruwaili A, De Jesus O. StatPearls [Internet]. 2023 [cited 2024 Feb 28]. Meningioma. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560538/
Alesi S, Forslund M, Melin J, Romualdi D, Peña A, Tay CT, et al. Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials. EClinicalMedicine. 2023 Sep;63:102162.
Ogasawara C, Philbrick BD, Adamson DC. Meningioma: A Review of Epidemiology, Pathology, Diagnosis, Treatment, and Future Directions. Biomedicines. 2021 Mar 21;9(3):319.
Patil CG, Laws ER. Meningioma: History of the Tumor and Its Management. In: Meningiomas. Elsevier; 2010. p. 3–9.
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021 Aug 2;23(8):1231–51.
Sahm F, Schrimpf D, Stichel D, Jones DTW, Hielscher T, Schefzyk S, et al. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol. 2017 May;18(5):682–94.
Nassiri F, Liu J, Patil V, Mamatjan Y, Wang JZ, Hugh-White R, et al. A clinically applicable integrative molecular classification of meningiomas. Nature. 2021 Sep 2;597(7874):119–25.
Elkady A, Soliman MAR, Ali AM. Clinical Outcomes of Infratentorial Meningioma Surgery in a Developing Country. World Neurosurg. 2020 May;137:e373–82.
Sahlu A, Laeke T, Kassahun A, Tirsit A, Debebe T, Gemechu T, et al. One Hundred Skull Base Meningiomas Operated at Black Lion Specialized Hospital, Addis Ababa, Ethiopia. World Neurosurg. 2019 Jun;126:e1321–9.
Raman SG, Prakash P, Sumit J, Bikram SD, Prasanna K. Clinical Outcome and Recurrence After Meningioma Surgery: An Experience from a Developing Country, Nepal. World Neurosurg. 2021 Apr;148:e138–44.
Maiuri F, Corvino S, Corazzelli G, Berardinelli J, Di Crescenzo RM, Del Basso De Caro M. Time to Recurrence of Intracranial Meningiomas from a Monoinstitutional Surgical Series. [Article in Press]. World Neurosurg. 2024 Feb;
Guadarrama-Ortíz P, Montes de Oca-Vargas I, Choreño-Parra JA, Gallegos-Garza C, Sánchez-Garibay C, Garibay-Gracián A, et al. Expression of IL-6 and matrix metalloproteinases in a convexity meningiomas with hyperostosis: Case report. Interdisciplinary Neurosurgery. 2022 Mar;27:101374.
Brokinkel B, Hess K, Mawrin C. Brain invasion in meningiomas—clinical considerations and impact of neuropathological evaluation: a systematic review. Neuro Oncol. 2017 Oct;19(10):1298–307.
Leclerc A, Gaberel T, Laville MA, Derrey S, Quintyn JC, Emery E. Predictive Factors of Favorable Visual Outcomes After Surgery of Tuberculum Sellae Meningiomas: A Multi-center Retrospective Cohort Study. World Neurosurg. 2022 Aug;164:e557–67.
Haeren RHL, Rautalin I, Schwartz C, Korja M, Niemelä M. Surgery on giant meningiomas in very old patients entails frequent postoperative intracranial hemorrhages and atypical histopathology. J Neurooncol. 2021 Mar 21;152(1):195–204.
Timmer M, Seibl-Leven M, Wittenstein K, Grau S, Stavrinou P, Röhn G, et al. Long-Term Outcome and Health-Related Quality of Life of Elderly Patients After Meningioma Surgery. World Neurosurg. 2019 May;125:e697–710.
Rafiq R, Katiyar V, Garg K, Kasliwal M, Chandra PS, Kale SS. Comparison of outcomes of surgery for intracranial meningioma in elderly and young patients – A systematic review and meta-analysis. Clin Neurol Neurosurg. 2021 Aug;207:106772.
Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016. Neuro Oncol. 2019 Nov 1;21(Supplement_5):v1–100.
Malueka RG, Hartanto RA, Setyawan NH, Fauzi DNF, Damarjati KR, Rismawan A, et al. Association of Hormonal Contraception with Meningioma Location in Indonesian Patients. Asian Pacific Journal of Cancer Prevention. 2022;23(3):1047–51.
Benson VS, Pirie K, Green J, Bull D, Casabonne D, Reeves GK, et al. Hormone replacement therapy and incidence of central nervous system tumours in the Million Women Study. Int J Cancer. 2010 Oct 4;127(7):1692–8.
Claus EB, Calvocoressi L, Bondy ML, Wrensch M, Wiemels JL, Schildkraut JM. Exogenous hormone use, reproductive factors, and risk of intracranial meningioma in females. J Neurosurg. 2013 Mar;118(3):649–56.
Harland T, Freeman J, Davern M, McCracken D, Celano E, Lillehei K, et al. Progester-one-only contraception is associated with a shorter progression-free survival in premenopausal women with WHO Grade I meningioma. J Neurooncol. 2018 Jan;136(2):327–33.
Andersen L, Friis S, Hallas J, Ravn P, Schrøder HD, Gaist D. Hormone replacement therapy increases the risk of cranial meningioma. Eur J Cancer [Internet]. 2013 Oct;49(15):3303–10. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0959804913004346
Cottin V, Blanchard E, Kerjouan M, Lazor R, Reynaud-Gaubert M, Taille C, et al. French recommendations for the diagnosis and management of lymphangioleiomyomatosis. Respir Med Res. 2023 Jun;83:101010.
Fan ZX, Shen J, Wu YY, Yu H, Zhu Y, Zhan RY. Hormone replacement therapy and risk of meningioma in women: a meta-analysis. Cancer Causes & Control. 2013 Aug 24;24(8):1517–25.
Yang X, Liu F, Zheng J, Cheng W, Zhao C, Di J. Relationship Between Oral Contraceptives and the Risk of Gliomas and Meningiomas: A Dose-Response Meta-Analysis and Systematic Review. World Neurosurg. 2021 Mar;147:e148–62.
McDonald MF, Khan B, English C, Chang A, Harmanci A, Harmanci A, et al. 378 Meningiomas Causing Bony Hyperostosis Upregulate Cell Adhesion, Bone Mineralization, and Bone Development Gene Signatures. Neurosurgery. 2024 Apr;70(Supplement_1):114114–114.
Anggraeni D, Diansari Y, Hafy Z. Demographic, Clinical, And Tumor Profile of Meningioma in Mohammad Hoesin Hospital Palembang, Indonesia. Biomedical Journal of Indonesia. 2022;8(1):1–4.
Meling TR, Da Broi M, Scheie D, Helseth E, Smoll NR. Meningioma Surgery–Are We Making Progress? World Neurosurg. 2019 May;125:e205–13.
Zhao L, Zhao W, Hou Y, Wen C, Wang J, Wu P, et al. An Overview of Managements in Meningiomas. Front Oncol. 2020 Aug 21;10.
Schipmann S, Sletvold TP, Wollertsen Y, Schwake M, Raknes IC, Miletić H, et al. Quality indicators and early adverse in surgery for atypical meningiomas: A 16-year single centre study and systematic review of the literature. Brain and Spine. 2023;3:101739.
Guadarrama-Ortíz P, Montes de Oca-Vargas I, Choreño-Parra JA, Gallegos-Garza C, Sánchez-Garibay C, Garibay-Gracián A, et al. Expression of IL-6 and matrix metalloproteinases in a convexity meningiomas with hyperostosis: Case report. Interdisciplinary Neurosurgery. 2022 Mar;27:101374.
Aage BM, Temkar P, Chemate S, Mangaleswaran B. Co-Existence of Atypical Meningio-ma, Intratumoral Lipometaplasia and Extensive Hyperostosis of Calvarium: A Rare Enti-ty. World Neurosurg X. 2019 Jan;1:100001.
Andrabi S, Sarmast A, Kirmani A, Bhat A. Cranioplasty: Indications, procedures, and out-come – An institutional experience. Surg Neurol Int. 2017;8(1):91.
Lee SC, Wu CT, Lee ST, Chen PJ. Cranioplasty using polymethyl methacrylate prostheses. Journal of Clinical Neuroscience. 2009 Jan;16(1):56–63.
Jaberi J, Gambrell K, Tiwana P, Madden C, Finn R. Long-Term Clinical Outcome Analysis of Poly-Methyl-Methacrylate Cranioplasty for Large Skull Defects. Journal of Oral and Maxillofacial Surgery. 2013 Feb;71(2):e81–8.
Article Metrics
Abstract view : 144 timesPDF - 10 times
DOI: https://doi.org/10.26714/magnamed.12.1.2025.17-30
Refbacks
- There are currently no refbacks.

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Indexed by
MAGNA MEDIKA by APKKM is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.